Your cart is currently empty!
Categories
- BPC-157
- CJC-1295 (with DAC)
- CJC-1295 No Dac
- Epithalon
- Follistatin
- General Peptide
- GHK-cu (Copper Peptide)
- GLP-1/GIP
- GnRH (Gonadotropin-Releasing Hormone)
- HCG (Human Chorionic Gonadotropin)
- Ipamorelin
- Kisspeptin
- Melanotan II (MT2)
- MK-677 (Ibutamoren)
- MOTS-c
- NAD+
- Oxytocin
- Peptide Storage
- Peptides
- PT-141 (Bremelanotide)
- Research Dosages
- Research Supplies
- Retatrutide
- Selank
- Semaglutide
- SNAP-8
- TB500 (Thymosin Beta-4)
- Tirzepatide
- Topical Peptides
Social Links
Power of GLP-1 for Drug, Alcohol Addiction, and Binge Eating
In addition to its use for weight loss and diabetes, there is a growing interest in the potential of GLP-1 receptor agonists for the treatment of various types of addiction, including opioid, cocaine, alcohol, binge eating, and other substance use disorders. While the research is still developing, several studies have suggested that GLP-1 receptor agonists…
Semaglutide Research Dosages
Below are suggested future clinical trial dosages that might be explored for weight loss research based-on studies performed for similar FDA approved GLP-1/GIP products that have already undergone several phases of clinical trials and testing. *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 –…
What is Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes. It works by stimulating insulin secretion and inhibiting glucagon secretion, leading to improved blood sugar control. In addition to its primary use in diabetes management, semaglutide has shown promising results in weight management as well. Studies…